Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference
BOSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment...